An internationalist team of researchers has just successfully finished the first human trials of a new malaria vaccine. Tested on 100 West African children susceptible to malaria, the trial showed a high level of relevant antibodies a year after the vaccine was administered.
From a Howard Hughes Medical Institute press release:
Plowe [Christopher V. Plowe, MD, MPH, a professor of medicine at the University of Maryland School of Medicine] and a group of U.S. and Belgian